|
Volumn 7, Issue 1, 2011, Pages 4-5
|
Drug discovery: New Btk inhibitor holds promise
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
AUTOANTIGEN;
B LYMPHOCYTE RECEPTOR;
BRUTON TYROSINE KINASE;
CGI 1746;
ENZYME INHIBITOR;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
PROTEIN KINASE SYK;
RITUXIMAB;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ARTICLE;
AUTOIMMUNE DISEASE;
B CELL LYMPHOMA;
BONE MARROW CELL;
CELL ACTIVATION;
CYTOKINE PRODUCTION;
DRUG MECHANISM;
ENZYME INHIBITION;
GENE MUTATION;
HUMAN;
LYMPHOCYTE DIFFERENTIATION;
LYMPHOCYTE PROLIFERATION;
MULTIPLE SCLEROSIS;
NONHUMAN;
PLASMA CELL;
PRIORITY JOURNAL;
PROTEIN CONFORMATION;
PROTEIN PHOSPHORYLATION;
RHEUMATOID ARTHRITIS;
SIGNAL TRANSDUCTION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
|
EID: 78650463027
PISSN: 15524450
EISSN: 15524469
Source Type: Journal
DOI: 10.1038/nchembio.502 Document Type: Article |
Times cited : (51)
|
References (9)
|